Cargando…
Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy
The therapeutic repertoire for tuberculosis (TB) remains limited despite the existence of many TB drugs that are highly active in in vitro models and possess clinical utility. Underlying the lack of efficacy in vivo is the inability of TB drugs to penetrate microenvironments inhabited by the causati...
Autores principales: | Tanner, Lloyd, Mashabela, Gabriel T., Omollo, Charles C., de Wet, Timothy J., Parkinson, Christopher J., Warner, Digby F., Haynes, Richard K., Wiesner, Lubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557888/ https://www.ncbi.nlm.nih.gov/pubmed/34585951 http://dx.doi.org/10.1128/Spectrum.00434-21 |
Ejemplares similares
-
Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis
por: Tanner, Lloyd, et al.
Publicado: (2020) -
De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis
por: Kipkorir, Terry, et al.
Publicado: (2021) -
An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
por: Tanner, Lloyd, et al.
Publicado: (2019) -
Harnessing Biological Insight to Accelerate Tuberculosis
Drug Discovery
por: de Wet, Timothy J., et al.
Publicado: (2019) -
Challenges in TB research
por: Scriba, Thomas J., et al.
Publicado: (2022)